Detalhe da pesquisa
1.
Evolution of HIV-1 envelope towards reduced neutralization sensitivity, as demonstrated by contemporary HIV-1 subtype B from the United States.
PLoS Pathog
; 19(12): e1011780, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38055771
2.
Evolution of Antibody Responses in HIV-1 CRF01_AE Acute Infection: Founder Envelope V1V2 Impacts the Timing and Magnitude of Autologous Neutralizing Antibodies.
J Virol
; 97(2): e0163522, 2023 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36749076
3.
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques.
Proc Natl Acad Sci U S A
; 118(38)2021 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34470866
4.
Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C gp145 Envelope for Use in Preclinical and Clinical Vaccine Research.
J Virol
; 89(15): 7478-93, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25972551
5.
Evaluation of Antibody-Dependent Fc-Mediated Viral Entry, as Compared With Neutralization, in SARS-CoV-2 Infection.
Front Immunol
; 13: 901217, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35711449
6.
A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates.
Sci Transl Med
; 14(632): eabi5735, 2022 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34914540
7.
Efficacy of a Broadly Neutralizing SARS-CoV-2 Ferritin Nanoparticle Vaccine in Nonhuman Primates.
bioRxiv
; 2021 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33791694
8.
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques.
bioRxiv
; 2021 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33851155
9.
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity.
Cell Rep
; 37(12): 110143, 2021 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34919799
10.
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity.
bioRxiv
; 2021 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34013273
11.
Novel monoclonal antibodies to the SERINC5 HIV-1 restriction factor detect endogenous andvirion-associated SERINC5.
MAbs
; 12(1): 1802187, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32835602
12.
Evaluation of HIV-1 neutralizing and binding antibodies in maternal-infant transmission in Thailand.
Virology
; 548: 152-159, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32838936
13.
Neutralization Sensitivity of a Novel HIV-1 CRF01_AE Panel of Infectious Molecular Clones.
J Acquir Immune Defic Syndr
; 78(3): 348-355, 2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29528942
14.
Antibody responses to prime-boost vaccination with an HIV-1 gp145 envelope protein and chimpanzee adenovirus vectors expressing HIV-1 gp140.
AIDS
; 30(16): 2405-2414, 2016 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-27525550
15.
Chemically modified peptides based on the membrane-proximal external region of the HIV-1 envelope induce high-titer, epitope-specific nonneutralizing antibodies in rabbits.
Clin Vaccine Immunol
; 21(8): 1086-93, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24872518
16.
Impact of HIV-1 backbone on neutralization sensitivity: neutralization profiles of heterologous envelope glycoproteins expressed in native subtype C and CRF01_AE backbone.
PLoS One
; 8(11): e76104, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24312165